Peter Koch
Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke
Gensicke H, Bonati L, Curtze S, Erdur H, Sibolt G, Koch P, Vandelli L, Ringleb P, Leys D, Cordonnier C, Michel P, Nolte C, Lyrer P, Tatlisumak T, Nederkoorn P, Engelter S, Peters N, Putaala J, Traenka C, Strbian D, Zinkstok S, Scheitz J, Bill O, Hametner C, Moulin S, Zini A, Kägi G, Pezzini A, Padjen V, Béjot Y, Corbiere S, Zonneveld T, Seiffge D, Roos Y. Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke. Stroke 2016; 47:450-6.
Feb 1, 2016Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke
Feb 1, 2016Stroke 2016; 47:450-6
Gensicke Henrik, Bonati Leo H, Curtze Sami, Erdur Hebun, Sibolt Gerli, Koch Peter, Vandelli Laura, Ringleb Peter, Leys Didier, Cordonnier Charlotte, Michel Patrik, Nolte Christian H, Lyrer Philippe A, Tatlisumak Turgut, Nederkoorn Paul J, Engelter Stefan T, Peters Nils, Putaala Jukka, Traenka Christopher, Strbian Daniel, Zinkstok Sanne M, Scheitz Jan F, Bill Olivier, Hametner Christian, Moulin Solène, Zini Andrea, Kägi Georg, Pezzini Alessandro, Padjen Visnja, Béjot Yannick, Corbiere Sydney, Zonneveld Thomas P, Seiffge David J, Roos Yvo B
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Behringer K, Lange E, Mahlberg R, Hassler A, Vogelhuber M, Hahn D, Mezger J, Krause S, Skoetz N, Böll B, von Tresckow B, Diehl V, Hallek M, Borchmann P, Stein H, Eich H, Engert A, Bentz M, Vieler T, Kriz J, Goergen H, Tanner A, Zijlstra J, Greil R, Markova J, Sasse S, Fuchs M, Topp M, Soekler M, Mathas S, Meissner J, Wilhelm M, Koch P, Lindemann H, Schalk E, Semrau R. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. Lancet 2014; 385:1418-27.
Dec 22, 2014Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Dec 22, 2014Lancet 2014; 385:1418-27
Behringer Karolin, Lange Elisabeth, Mahlberg Rolf, Hassler Andre, Vogelhuber Martin, Hahn Dennis, Mezger Jörg, Krause Stefan W, Skoetz Nicole, Böll Boris, von Tresckow Bastian, Diehl Volker, Hallek Michael, Borchmann Peter, Stein Harald, Eich Hans, Engert Andreas, Bentz Martin, Vieler Tom, Kriz Jan, Goergen Helen, Tanner Antonia, Zijlstra Josée M, Greil Richard, Markova Jana, Sasse Stephanie, Fuchs Michael, Topp Max S, Soekler Martin, Mathas Stephan, Meissner Julia, Wilhelm Martin, Koch Peter, Lindemann Hans-Walter, Schalk Enrico, Semrau Robert